Sumitomo Yuka | Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of He

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PJ-070 Exaggerated Atherosclerosis in Heparin Cofactor II-Deficient ApoE Knockout Mice(Atherosclerosis, basic-8, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Infective Endocarditis Caused by Lactobacillus
Improvement of Cardiac Diastolic Function and Prognosis After Autologous Peripheral Blood Stem Cell Transplantation in AL Cardiac Amyloidosis
PE-347 Early Detection of Myocardial Damage in Female Carriers of Duchenne Muscular Dystrophy : the Utility of Cardiac Magnetic Resonance(PE058,Cardiomyopathy/Hypertrophy (Clinical) 1 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The
DPE-042 Plasma Aldosterone Concentration is Associated with Cognitive Impairement in Patients with Hypertension(DPE07,Hypertension, Clinical (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
OE-366 Bosentan, an Endothelin Receptor Antagonist, Exerts Protective Actions against Systemic Sclerosis-related Peripheral Circulation Insufficiency(OE62,Peripheral Circulation/Vascular Disease (Therapy) (H),Oral Presentation (English),The 73rd Annual Sc
OE-213 Pitavastatin Exerts LDL Cholesterol Reduction-independent Protective Action for Cardiac and Renal Function in Patients with Dyslipidemia(OE36,Atherosclerosis (Clinical/Treatment) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting
Heparin Cofactor II is an Independent Protective Factor against Peripheral Arterial Disease in Elderly Subjects with Cardiovascular Risk Factors
PE-209 Pitavastatin Excretes eNOS-independent Protective Action against Angiotensin II-induced Atrial Remodeling through Attenuating Rac1-madiated Oxidative Stress(PE035,Cardiovascular Pharmacology (Basic) (H),Poster Session (English),The 73rd Annual Scie
PE-163 HMG-CoA Reductase Inhibitor Pitavastatin Increases the Expression of Endothelial NOS through Activation of ERK5-KLF2 Pathway in Vascular Endothelial Cells(Cardiovascular pharmacology, basic/clinical(03)(H),Poster Session(English),The 72nd Annual Sc
OE-024 An eNOS-independent Protective Action of Pitavastatin against Angiotensin II-induced Cardiorenal Damage through Attenuating Rac-1-mediated Oxidative Stress(Cardiovascular pharmacology, basic/clinical(01)(H),Oral Presentation(English),The 72nd Annua
PE-570 Therapeutic Angiogenesis by Transplantation of Atologous Peripheral-blood Mononuclear Cells Mobilized by Human Recombinant Erythropoietin in Patients with Severe Limb Ischemia(Regeneration (angiogenesis/myocardial regeneration)-4, The 71st Annual S
PE-390 Glucocorticoid-induced Vascular Endothelial Dysfunction and Hypertension are Ameliorated by Pitavastatin, an HMG-CoA Reductase Inhibitor, through Increased Nitric Oxide Production(Cardiovascular pharmacology, basic/clinical-4, The 71st Annual Scien
OE-211 A Novel eNOS-independent Action of an HMG-CoA Reductase Inhibitor against Angiotensin II-induced Cardiovascular Remodeling(Cardiovascular pharmacology, basic/clinical-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-564 Dehydroepiandrosterone Sulfate is an Antivascular Remodeling Factor(PE095,Atherosclerosis (Clinical/Pathophysiology) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
DPE-065 A Combination of Erythropoietin Administration with Autologous Blood Donation for Therapeutic Angiogenesis(DPE11,Kidney/Renal Circulation/CKD (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Socie

もっと見る

スポンサーリンク